thyroxine has been researched along with Follicular Thyroid Carcinoma in 89 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range." | 7.73 | Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006) |
| "The aim was to analyze the impact of combined treatment (thyroidectomy + radioactive iodine treatment + hormonotherapy with thyroxine) on the outcomes of patients with follicular thyroid carcinoma." | 3.76 | [Outcomes of long-term combined treatment in follicular thyroid carcinoma]. ( Baranauskas, Z; Tiskevicius, S; Valuckas, KP, 2010) |
| " The skull and brain tumors had been successfully treated by surgery, thyroxine supplementation, and radiosurgery until she died of sudden intracerebral hemorrhage which had no connection with tumor treatment." | 3.73 | Thyroid follicular carcinoma metastasized to the lung, skull, and brain 12 years after initial treatment for thyroid gland--case report. ( Ogawa, Y; Sakuma, T; Seki, H; Sugawara, T, 2006) |
| "We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range." | 3.73 | Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006) |
| " In papillary carcinoma thyroxine administration (P < 0." | 3.69 | Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival. ( Staunton, MD, 1994) |
| "These negative findings, that thyroxine in suppressive doses does not significantly reduce bone mineral density in New Zealand patients suggest that thyroxine therapy alone is not a major risk factor for the development of osteoporosis." | 3.68 | Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma. ( Ayling, EM; Brownlie, BE; Elliot, JR; Florkowski, CM; Turner, JG, 1993) |
| " Multivariate regression modelling was applied to assess the association of T4 dosing with polymorphisms in UGT1A1 (rs8175347), UGT1A3 (rs3806596 and rs1983023), DIO1 (rs11206244 and rs2235544) and DIO2 (rs225014 and rs12885300), demographic and clinical variables." | 2.79 | Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. ( Barros Filho, Mde C; Bulzico, DA; Kowalski, LP; Meirelles, RM; Neves, RR; Paula, DP; Pessoa, CN; Santoro, AB; Struchine, CJ; Suarez-Kurtz, G; Vargens, DD, 2014) |
| "Distant metastases from thyroid cancer of follicular origin are uncommon." | 2.58 | Treatment of refractory thyroid cancer. ( Berdelou, A; Klain, M; Lamartina, L; Leboulleux, S; Schlumberger, M, 2018) |
| "Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has increased over the last few decades." | 2.55 | Differentiated Thyroid Cancer-Treatment: State of the Art. ( Grosse, J; Hellwig, D; Menhart, K; Schmidbauer, B, 2017) |
| "The management of nodules and thyroid cancer is evolving." | 2.53 | Advances in the management of differentiated thyroid cancer with follicular cell strain. ( Ben Ali, M; Ben Raies, N; Ben Slimène, F; Karboua, E; Mhiri, A; Schlumberger, M; Slimène, H, 2016) |
| "Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all human tumors." | 2.48 | Approach to and treatment of differentiated thyroid carcinoma. ( Castagna, MG; Pacini, F, 2012) |
| "We retrospectively reviewed 234 follicular thyroid carcinoma cases to compare the diagnostic and therapeutic characteristics between the minimally and the widely invasive types." | 2.47 | Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. ( Chao, TC; Hsueh, C; Huang, CC; Lin, JD; Liu, FH, 2011) |
| "Papillary and follicular thyroid carcinomas are among the most curable of all cancers." | 2.41 | Papillary and follicular thyroid carcinoma. ( Schlumberger, MJ; Torlantano, M, 2000) |
| "In differentiated thyroid cancer (DTC), the standard treatment includes total thyroidectomy and lifetime levothyroxine (LT4) replacement." | 1.62 | Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer. ( Altuntaş, SÇ; Hocaoğlu, Ç, 2021) |
| "Thyroid cancer is on the rise." | 1.43 | SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. ( Cheng, SY; Kim, DW; Willingham, MC; Zhao, L; Zhu, X, 2016) |
| "In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease." | 1.40 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014) |
| "Hypothyroidism is a common endocrine disorder frequently accompanied by alterations in lipid metabolism, such as hypercholesterolemia and high circulating triglycerides, both risk factors for nonischemic cardiomyopathy." | 1.40 | Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function. ( Baumgartner-Parzer, S; Duan, H; Einwallner, E; Gessl, A; Hoffmann, M; Krebs, M; Krššák, M; Luger, A; Niessner, A; Scherer, T; Trattnig, S; Winhofer, Y; Wolf, P, 2014) |
| "While papillary and follicular thyroid cancer usually has an excellent prognosis, recurrent and aggressive forms of the disease do occur." | 1.36 | [Follow-up of papillary and follicular thyroid cancer--when and where?]. ( Mäenpää, HO; Välimäki, MJ, 2010) |
| "Tetraiodothyroacetic acid (tetrac) is a deaminated analogue of L-thyroxine that blocks the actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine at the cell surface receptor for thyroid hormone on integrin alpha v beta 3." | 1.36 | Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma. ( Bharali, DJ; Davis, FB; Davis, PJ; Dier, E; Dyskin, E; Lansing, L; Mousa, SA; Mousa, SS; Yalcin, M, 2010) |
| "Trifluralin treatment increased bile flow, caused a 3." | 1.35 | Mechanism of trifluralin-induced thyroid tumors in rats. ( Bartels, MJ; Brzak, KA; Charles, GD; Clark, AJ; Dryzga, MD; Kan, LH; Saghir, SA, 2008) |
| "In conclusion, these data indicate that thyroid neoplasms observed in the nelfinavir-treated rats were secondary to thyroid hormone imbalance." | 1.33 | Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia. ( Burns-Naas, LA; Capen, CC; Chen, M; Cook, JC; Evering, W; Furman, G; Gasser, R; Ivett, JL; Jessen, B; McClain, RM; Ryan, TE; Shetty, B; Stevens, G; Theiss, JC; Webber, S; Wu, E; Zorbas, M, 2005) |
| "Eleven children with differentiated thyroid cancer were included." | 1.33 | Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. ( Huang, SA; Kuijt, WJ, 2005) |
| "Detection of thyroid cancer by thyroglobulin (Tg) assay in peripheral blood is useful in the absence of residual thyroid tissue, but it requires thyrotropin stimulation for maximal sensitivity and is affected by circulating antithyroglobulin antibodies." | 1.32 | Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer. ( Delfino, C; Denizot, A; Dutour-Meyer, A; Fina, F; Ouafik, L, 2003) |
| "We report a case of follicular thyroid carcinoma discovered after surgical treatment of a toxic multinodular goiter, in which solitary adrenal gland metastasis was detected five years later." | 1.31 | Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism. ( López-Aznar, D; Ponce, JL; Prieto, M; Sancho-Fornos, S; Yunta, PJ, 2001) |
| "Lymph node metastases were detected in 5 of these patients by whole body scan (WBS) and removed surgically in 3." | 1.31 | Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. ( Cavaliere, H; Knobel, M; Lima, N; Medeiros-Neto, G; Tomimori, E, 2002) |
| "In 13 patients with macrometastases-tumors 1 cm or greater-tumors progressed and serum Tg increased; five have died of thyroid cancer." | 1.31 | Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. ( Fatourechi, V; Gorman, CA; Hay, ID; Javedan, H; Mullan, BP; Wiseman, GA, 2002) |
| "In 3 patients papillary thyroid cancer was associated with chronic lymphocytic thyroiditis." | 1.30 | Thyroid carcinoma in children and adolescents. ( Andreoli, M; Danese, D; Farsetti, A; Gardini, A; Pontecorvi, A; Sciacchitano, S, 1997) |
| "The most probable cause of the inadequate TSH suppression in our patients was the reduction in bioavailability in certain batches of Levothroid, although we are unable to rule out the possibility that the results obtained after the changeover to Dexnon were due to its greater bioavailability." | 1.30 | Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma. ( Almaraz, MC; Garriga, MJ; Gonzalez-Romero, S; Olveira, G; Ruiz de Adana, MS; Soriguer, F; Tinahones, F, 1997) |
| "One liver metastasis could not be detected because of the physiologic tracer distribution of 99mTc-tetrofosmin." | 1.30 | Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. ( Gallowitsch, HJ; Gomez, I; Kresnik, E; Lind, P; Mikosch, P; Unterweger, O, 1998) |
| "The ideal therapy for differentiated thyroid cancer is uncertain." | 1.30 | Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. ( Ain, KB; Bigos, ST; Brierley, JD; Cooper, DS; Haugen, BR; Ho, M; Klein, I; Ladenson, PW; Maxon, HR; Robbins, J; Ross, DS; Sherman, SI; Specker, B; Sperling, M; Taylor, T, 1998) |
| "Patients with thyroid cancer are monitored for disease recurrence by measurement of serum thyroglobulin (Tg) and iodine-131 (131I) scanning." | 1.30 | Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. ( Anderson, JS; Balducci-Silano, PL; Burman, KD; Francis, GL; Ladenson, PW; Levine, MA; Ringel, MD; Silverman, J; Sparling, YH; Spencer, CA; Tuttle, RM; Wartofsky, L, 1999) |
| "In the follicular thyroid carcinoma line FTC-133, nanomolar concentrations of 9-cis, 13-cis-, and all-trans-RA induced 5'DI activity." | 1.29 | Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. ( Köhrle, J; Schmutzler, C; Schnieders, F; Schreck, R, 1994) |
| "In a study of 136 differentiated thyroid cancer patients referred for radioiodine therapy since January 1991, it was observed that 80 patients had metastatic disease." | 1.29 | Thyroid hormones in differentiated thyroid cancer. ( Desai, KB; Mehta, MN; Samuel, AM, 1994) |
| "The patient presented recurrences of metastatic skin nodules, lung and bone metastases, and died after a 3-year follow-up." | 1.29 | Cutaneous metastasis from follicular carcinoma of the thyroid gland. ( Bazex, J; Caron, P; Gorguet, B; Moreau-Cabarrot, A, 1993) |
| "in an advanced stage with multiple metastases in the skeletal system, lungs and hilar lymph nodes." | 1.29 | [T3 hyperthyroidism with metastatic follicular thyroid carcinoma in substitution therapy]. ( Flesch, M; Lang, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (25.84) | 18.2507 |
| 2000's | 36 (40.45) | 29.6817 |
| 2010's | 28 (31.46) | 24.3611 |
| 2020's | 2 (2.25) | 2.80 |
| Authors | Studies |
|---|---|
| Altuntaş, SÇ | 1 |
| Hocaoğlu, Ç | 1 |
| van Veelen, NM | 1 |
| Fischli, S | 1 |
| Beeres, FJP | 1 |
| Eisenhut, T | 1 |
| Babst, R | 1 |
| Henzen, C | 1 |
| Link, BC | 1 |
| Schmidbauer, B | 1 |
| Menhart, K | 1 |
| Hellwig, D | 1 |
| Grosse, J | 1 |
| Fussey, JM | 1 |
| Khan, H | 1 |
| Ahsan, F | 1 |
| Prashant, R | 1 |
| Pettit, L | 1 |
| Berdelou, A | 1 |
| Lamartina, L | 1 |
| Klain, M | 2 |
| Leboulleux, S | 2 |
| Schlumberger, M | 4 |
| Li, P | 1 |
| Zhang, A | 1 |
| Liu, Y | 1 |
| Xu, C | 1 |
| Tang, L | 1 |
| Yuan, H | 1 |
| Liu, Q | 1 |
| Wang, X | 1 |
| Feng, D | 1 |
| Wang, L | 1 |
| Huang, G | 1 |
| Song, S | 1 |
| Mousavi, Z | 1 |
| Dourandish, L | 1 |
| Rokni, H | 1 |
| Sadeghi, R | 1 |
| Rasoul Zakavi, S | 1 |
| Ciappuccini, R | 1 |
| Hardouin, J | 1 |
| Heutte, N | 1 |
| Vaur, D | 1 |
| Quak, E | 1 |
| Rame, JP | 1 |
| Blanchard, D | 1 |
| de Raucourt, D | 1 |
| Bardet, S | 1 |
| Santoro, AB | 1 |
| Vargens, DD | 1 |
| Barros Filho, Mde C | 1 |
| Bulzico, DA | 1 |
| Kowalski, LP | 1 |
| Meirelles, RM | 1 |
| Paula, DP | 1 |
| Neves, RR | 1 |
| Pessoa, CN | 1 |
| Struchine, CJ | 1 |
| Suarez-Kurtz, G | 1 |
| Scherer, T | 1 |
| Wolf, P | 1 |
| Winhofer, Y | 1 |
| Duan, H | 1 |
| Einwallner, E | 1 |
| Gessl, A | 1 |
| Luger, A | 1 |
| Trattnig, S | 1 |
| Hoffmann, M | 1 |
| Niessner, A | 1 |
| Baumgartner-Parzer, S | 1 |
| Krššák, M | 1 |
| Krebs, M | 1 |
| Handkiewicz-Junak, D | 1 |
| Gawlik, T | 1 |
| Rozkosz, J | 1 |
| Puch, Z | 1 |
| Michalik, B | 1 |
| Gubala, E | 1 |
| Krajewska, J | 1 |
| Kluczewska, A | 1 |
| Jarzab, B | 1 |
| Shen, J | 1 |
| Wang, S | 1 |
| Zhao, X | 1 |
| Shao, X | 1 |
| Jiang, X | 1 |
| Dai, Y | 1 |
| Xu, S | 1 |
| Pan, X | 1 |
| Zubarovskiy, IN | 1 |
| Mikhailova, MV | 1 |
| Osipenko, SK | 1 |
| Zhu, X | 1 |
| Kim, DW | 1 |
| Zhao, L | 2 |
| Willingham, MC | 2 |
| Cheng, SY | 2 |
| Ben Slimène, F | 1 |
| Mhiri, A | 1 |
| Ben Ali, M | 1 |
| Slimène, H | 1 |
| Ben Raies, N | 1 |
| Karboua, E | 1 |
| Kim, HJ | 1 |
| Mok, JO | 1 |
| Kim, CH | 1 |
| Kim, YJ | 1 |
| Kim, SJ | 1 |
| Park, HK | 1 |
| Byun, DW | 1 |
| Suh, K | 1 |
| Yoo, MH | 1 |
| Mousa, U | 1 |
| Yikilmaz, AS | 1 |
| Nar, A | 1 |
| Nar Demirer, A | 1 |
| Ayturk, S | 1 |
| Tutuncu, NB | 1 |
| Gursoy, A | 1 |
| Pak, Y | 1 |
| Demirag, NG | 1 |
| Saghir, SA | 1 |
| Charles, GD | 1 |
| Bartels, MJ | 1 |
| Kan, LH | 1 |
| Dryzga, MD | 1 |
| Brzak, KA | 1 |
| Clark, AJ | 1 |
| Huang, CC | 1 |
| Hsueh, C | 1 |
| Liu, FH | 1 |
| Chao, TC | 1 |
| Lin, JD | 1 |
| Ogawa, C | 1 |
| Kammori, M | 1 |
| Onose, H | 1 |
| Yamada, E | 1 |
| Shimizu, K | 1 |
| Yamada, T | 1 |
| Gen, R | 1 |
| Akbay, E | 1 |
| Camsari, A | 1 |
| Ozcan, T | 1 |
| Vera, P | 1 |
| Kuhn-Lansoy, C | 1 |
| Edet-Sanson, A | 1 |
| Hapdey, S | 1 |
| Modzelewski, R | 1 |
| Hitzel, A | 1 |
| d'Anjou, J | 1 |
| Basuyau, JP | 1 |
| Conwell, LS | 1 |
| Greer, ML | 1 |
| Stewart, A | 1 |
| Perry, CF | 1 |
| Lu, C | 1 |
| Ying, H | 1 |
| Yalcin, M | 1 |
| Bharali, DJ | 1 |
| Dyskin, E | 1 |
| Dier, E | 1 |
| Lansing, L | 1 |
| Mousa, SS | 1 |
| Davis, FB | 1 |
| Davis, PJ | 1 |
| Mousa, SA | 1 |
| Taïeb, D | 1 |
| Sebag, F | 1 |
| Farman-Ara, B | 1 |
| Portal, T | 1 |
| Baumstarck-Barrau, K | 1 |
| Fortanier, C | 1 |
| Bourrelly, M | 1 |
| Mancini, J | 1 |
| De Micco, C | 1 |
| Auquier, P | 1 |
| Conte-Devolx, B | 1 |
| Henry, JF | 1 |
| Mundler, O | 1 |
| Nunes, Vdos S | 1 |
| Tagliarini, JV | 1 |
| Marques, ME | 1 |
| de Godoi, JA | 1 |
| Mazeto, GM | 1 |
| Baranauskas, Z | 1 |
| Valuckas, KP | 1 |
| Tiskevicius, S | 1 |
| Mäenpää, HO | 1 |
| Välimäki, MJ | 1 |
| Reverter, JL | 1 |
| Colomé, E | 1 |
| Kim, KW | 1 |
| Park, YJ | 1 |
| Kim, EH | 1 |
| Park, SY | 1 |
| Park, DJ | 2 |
| Ahn, SH | 1 |
| Jang, HC | 1 |
| Cho, BY | 1 |
| Luna, R | 1 |
| Penín, M | 1 |
| Seoane, I | 1 |
| Alvarez, E | 1 |
| Palmeiro, R | 1 |
| García-Mayor, R | 1 |
| Pacini, F | 3 |
| Castagna, MG | 1 |
| Kasner, DL | 1 |
| Spieth, ME | 1 |
| Starkman, ME | 1 |
| Zdor-North, D | 1 |
| Kim, BW | 1 |
| Daniels, GH | 1 |
| Harrison, BJ | 1 |
| Price, A | 1 |
| Harney, JW | 1 |
| Larsen, PR | 1 |
| Weetman, AP | 1 |
| Baudin, E | 2 |
| Son, HY | 1 |
| Nishikawa, A | 1 |
| Kanki, K | 1 |
| Okazaki, K | 1 |
| Kitamura, Y | 1 |
| Lee, KY | 1 |
| Umemura, T | 1 |
| Hirose, M | 1 |
| Zöphel, K | 1 |
| Wunderlich, G | 1 |
| Smith, BR | 1 |
| Denizot, A | 1 |
| Delfino, C | 1 |
| Dutour-Meyer, A | 1 |
| Fina, F | 1 |
| Ouafik, L | 1 |
| Golger, A | 1 |
| Fridman, TR | 1 |
| Eski, S | 1 |
| Witterick, IJ | 1 |
| Freeman, JL | 1 |
| Walfish, PG | 1 |
| Woodrum, DT | 1 |
| Gauger, PG | 1 |
| Kuijt, WJ | 1 |
| Huang, SA | 1 |
| Pace, L | 1 |
| Albanese, C | 1 |
| Salvatore, B | 1 |
| Storto, G | 1 |
| Soricelli, A | 1 |
| Salvatore, M | 1 |
| Burns-Naas, LA | 1 |
| Zorbas, M | 1 |
| Jessen, B | 1 |
| Evering, W | 1 |
| Stevens, G | 1 |
| Ivett, JL | 1 |
| Ryan, TE | 1 |
| Cook, JC | 1 |
| Capen, CC | 1 |
| Chen, M | 1 |
| Furman, G | 1 |
| Theiss, JC | 1 |
| Webber, S | 1 |
| Wu, E | 1 |
| Shetty, B | 1 |
| Gasser, R | 1 |
| McClain, RM | 1 |
| Ogawa, Y | 1 |
| Sugawara, T | 1 |
| Seki, H | 1 |
| Sakuma, T | 1 |
| Takano, T | 1 |
| Miyauchi, A | 2 |
| Ito, Y | 2 |
| Amino, N | 2 |
| do Rosário, PW | 1 |
| Borges, MA | 1 |
| Alves, MF | 1 |
| Purisch, S | 1 |
| Padrão, EL | 1 |
| Rezende, LL | 1 |
| Barroso, AL | 1 |
| Santos, RB | 1 |
| Melo, TG | 1 |
| Assumpção, LV | 1 |
| Tajiri, J | 1 |
| Takamura, Y | 1 |
| Miya, A | 1 |
| Kobayashi, K | 1 |
| Matsuzuka, F | 1 |
| Toyoda, N | 1 |
| Nomura, E | 1 |
| Nishikawa, M | 1 |
| David, E | 1 |
| Rosen, IB | 1 |
| Bain, J | 1 |
| James, J | 1 |
| Kirsh, JC | 1 |
| Mariotti, S | 1 |
| Barbesino, G | 1 |
| Caturegli, P | 1 |
| Marinò, M | 1 |
| Manetti, L | 1 |
| Fugazzola, L | 1 |
| Pinchera, A | 1 |
| Francia, G | 1 |
| Davì, MV | 1 |
| Petroziello, A | 1 |
| Sussi, PL | 1 |
| Staunton, MD | 1 |
| Schreck, R | 1 |
| Schnieders, F | 1 |
| Schmutzler, C | 1 |
| Köhrle, J | 1 |
| Samuel, AM | 1 |
| Mehta, MN | 1 |
| Desai, KB | 1 |
| Florkowski, CM | 1 |
| Brownlie, BE | 1 |
| Elliot, JR | 1 |
| Ayling, EM | 1 |
| Turner, JG | 1 |
| Betkowski, A | 1 |
| Gotkowska, K | 1 |
| Rzepka, M | 1 |
| Caron, P | 1 |
| Moreau-Cabarrot, A | 1 |
| Gorguet, B | 1 |
| Bazex, J | 1 |
| Lang, M | 1 |
| Flesch, M | 1 |
| Danese, D | 1 |
| Gardini, A | 1 |
| Farsetti, A | 1 |
| Sciacchitano, S | 1 |
| Andreoli, M | 1 |
| Pontecorvi, A | 1 |
| Grobholz, R | 1 |
| Bittinger, A | 1 |
| Gerdes, B | 1 |
| Rothmund, M | 1 |
| Olveira, G | 1 |
| Almaraz, MC | 1 |
| Soriguer, F | 1 |
| Garriga, MJ | 1 |
| Gonzalez-Romero, S | 1 |
| Tinahones, F | 1 |
| Ruiz de Adana, MS | 1 |
| Naito, Y | 1 |
| Sone, T | 1 |
| Kataoka, K | 1 |
| Sawada, M | 1 |
| Yamazaki, K | 1 |
| Obiols, G | 1 |
| Simó, R | 1 |
| Burgos, R | 1 |
| Tresserras, R | 1 |
| Galofré, P | 1 |
| Masmiquel, L | 1 |
| Hernández, C | 1 |
| Mesa, J | 1 |
| Gallowitsch, HJ | 1 |
| Mikosch, P | 1 |
| Kresnik, E | 1 |
| Unterweger, O | 1 |
| Gomez, I | 1 |
| Lind, P | 1 |
| Travagli, JP | 1 |
| Cailleux, AF | 1 |
| Ricard, M | 1 |
| Caillou, B | 1 |
| Parmentier, C | 1 |
| Konukoğlu, D | 1 |
| Hatemi, HH | 1 |
| Arikan, S | 1 |
| Demir, M | 1 |
| Akçay, T | 1 |
| Cooper, DS | 1 |
| Specker, B | 1 |
| Ho, M | 1 |
| Sperling, M | 1 |
| Ladenson, PW | 2 |
| Ross, DS | 1 |
| Ain, KB | 1 |
| Bigos, ST | 1 |
| Brierley, JD | 1 |
| Haugen, BR | 1 |
| Klein, I | 1 |
| Robbins, J | 1 |
| Sherman, SI | 1 |
| Taylor, T | 1 |
| Maxon, HR | 1 |
| Unal, S | 1 |
| Menda, Y | 1 |
| Adalet, I | 1 |
| Boztepe, H | 1 |
| Ozbey, N | 1 |
| Alagöl, F | 1 |
| Cantez, S | 1 |
| Garcia-Sanchis, L | 1 |
| Lopez-Aznar, D | 2 |
| Oltra, A | 1 |
| Rivas, A | 1 |
| Alonso, J | 1 |
| Montalar, J | 1 |
| Mateo, A | 1 |
| Ringel, MD | 1 |
| Balducci-Silano, PL | 1 |
| Anderson, JS | 1 |
| Spencer, CA | 1 |
| Silverman, J | 1 |
| Sparling, YH | 1 |
| Francis, GL | 1 |
| Burman, KD | 1 |
| Wartofsky, L | 1 |
| Levine, MA | 1 |
| Tuttle, RM | 1 |
| Schlumberger, MJ | 2 |
| Schneider, PW | 1 |
| Meier, DA | 1 |
| Balon, H | 1 |
| Mariani, G | 1 |
| Ferdeghini, M | 1 |
| Augeri, C | 1 |
| Villa, G | 1 |
| Taddei, GZ | 1 |
| Scopinaro, G | 1 |
| Boni, G | 1 |
| Bodei, L | 1 |
| Rabitti, C | 1 |
| Molinari, E | 1 |
| Bianchi, R | 1 |
| Almeida-Filho, P | 1 |
| Ravizzini, GC | 1 |
| Almeida, C | 1 |
| Borges-Neto, S | 1 |
| Kondo, T | 1 |
| Katoh, R | 1 |
| Omata, K | 1 |
| Oyama, T | 1 |
| Yagawa, A | 1 |
| Kawaoi, A | 1 |
| Moog, F | 1 |
| Linke, R | 1 |
| Manthey, N | 1 |
| Tiling, R | 1 |
| Knesewitsch, P | 1 |
| Tatsch, K | 1 |
| Hahn, K | 1 |
| Hrafnkelsson, J | 1 |
| Tulinius, H | 1 |
| Kjeld, M | 1 |
| Sigvaldason, H | 1 |
| Jónasson, JG | 1 |
| Torlantano, M | 1 |
| Haslinghuis, LM | 1 |
| Krenning, EP | 2 |
| De Herder, WW | 1 |
| Reijs, AE | 1 |
| Kwekkeboom, DJ | 1 |
| Yunta, PJ | 1 |
| Ponce, JL | 1 |
| Prieto, M | 1 |
| Sancho-Fornos, S | 1 |
| Lima, N | 1 |
| Cavaliere, H | 1 |
| Tomimori, E | 1 |
| Knobel, M | 1 |
| Medeiros-Neto, G | 1 |
| Fatourechi, V | 1 |
| Hay, ID | 1 |
| Javedan, H | 1 |
| Wiseman, GA | 1 |
| Mullan, BP | 1 |
| Gorman, CA | 1 |
| de Geus-Oei, LF | 1 |
| Oei, HY | 1 |
| Hennemann, G | 1 |
| Arici, C | 1 |
| Erdogan, O | 1 |
| Altunbas, H | 1 |
| Boz, A | 1 |
| Melikoglu, M | 1 |
| Karayalcin, B | 1 |
| Karpuzoglu, T | 1 |
| Ishihara, T | 1 |
| Ikekubo, K | 1 |
| Shimodahira, M | 1 |
| Iwakura, T | 1 |
| Kobayashi, M | 1 |
| Hino, M | 1 |
| Oobayashi, M | 1 |
| Kohno, K | 1 |
| Kimura, K | 1 |
| Kawamura, S | 1 |
| Kurahachi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples[NCT06133374] | 130 participants (Anticipated) | Observational | 2023-12-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for thyroxine and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Compartment syndrome of the leg after thyroid hormone withdrawal; two cases and a systematic review of the literature.
Topics: Adenocarcinoma, Follicular; Anterior Compartment Syndrome; Compartment Syndromes; Deprescriptions; F | 2020 |
Differentiated Thyroid Cancer-Treatment: State of the Art.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Drug Therapy; Enzyme Inhibitors; H | 2017 |
Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Drug Therapy, Combination; Evidence-Based Med | 2017 |
Treatment of refractory thyroid cancer.
Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Humans; Iodine Radioisotopes; Thyroid Neoplas | 2018 |
Skull metastasis from follicular thyroid carcinoma: report of three cases and review of literature.
Topics: Adenocarcinoma, Follicular; Aged; Biomarkers, Tumor; Biopsy; Cranial Irradiation; Craniotomy; Diseas | 2015 |
Advances in the management of differentiated thyroid cancer with follicular cell strain.
Topics: Adenocarcinoma, Follicular; Hormone Replacement Therapy; Humans; Iodine Radioisotopes; Neoplasm Recu | 2016 |
Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Female; Frozen Sections; Humans; Male; Middle Aged; Retrosp | 2011 |
[Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Aged; Bone Remodeling; Carcinoma, Papillary; Cardiovascular Diseases; Co | 2011 |
Approach to and treatment of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma; Carcinoma, Papillary; Cell Differentiation; Combined Modality | 2012 |
Follow-up of differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Biomarkers, Tumor; Carcinoma, Papillary; Combined Modali | 2002 |
Follow-up of thyroid cancer patients with favorable prognostic indicators.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Follow-Up Studies; Humans; Iodine Radioisotopes; N | 2003 |
Role of 131I in the treatment of well differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Combined Modality | 2005 |
[Familial nommedullary thyroid cancer].
Topics: Adenocarcinoma, Follicular; Age Factors; Carcinoma, Papillary; Early Diagnosis; Female; Genetic Pred | 2007 |
[Approach to thyroid incidentaloma and follicular adenoma].
Topics: Adenocarcinoma, Follicular; Adenoma; Biopsy, Fine-Needle; Diagnosis, Differential; Diagnostic Imagin | 2007 |
Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Neoplasm Recurrence, | 1999 |
Papillary and follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Iodine Radioisotopes; Neoplasm Metastasis; | 2000 |
4 trials available for thyroxine and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Body Weight; Carcinoma, Papillary; Dose-Response Relationship, Dr | 2014 |
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Cohort Studies; Dose-Response Re | 2014 |
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
Topics: Ablation Techniques; Adenocarcinoma, Follicular; Carcinoma, Papillary; Combined Modality Therapy; Ha | 2010 |
[Should thyroxine treatment be discontinued for four weeks before I(131) thyroid ablation?].
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Chi-Square Distribution; Drug Adminis | 2012 |
69 other studies available for thyroxine and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Asymptomatic Diseases; Case-Control Studies; Ch | 2021 |
Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management.
Topics: Adenocarcinoma, Follicular; Adult; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Precisio | 2019 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad | 2014 |
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Electrocardiography; Female; Heart; Hormone | 2014 |
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Carcinoma; Carcinoma, Papillary; Child; Humans; Iodine Radio | 2015 |
[LONG-TERM RESULTS OF SURGICAL TREATMENT OF PATIENTS WITH FOLLICULAR TUMORS OF THE THYROID].
Topics: Adenocarcinoma, Follicular; Adenoma; Adult; Aged; Diagnosis, Differential; Female; Hormone Replaceme | 2015 |
SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Topics: Adenocarcinoma, Follicular; Animals; Carcinogenesis; Disease Models, Animal; Hydroxamic Acids; Mice, | 2016 |
Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Female; Humans; Male; Middle Aged; Preop | 2017 |
Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Catheter Ablation; Female; Follow- | 2017 |
Unresectable huge sternal and mediastinal metastasis of follicular thyroid carcinoma; radiotherapy as first-line and palliative therapy.
Topics: Adenocarcinoma, Follicular; Female; Humans; Iodine Radioisotopes; Mediastinal Neoplasms; Middle Aged | 2009 |
Mechanism of trifluralin-induced thyroid tumors in rats.
Topics: Adenocarcinoma, Follicular; Administration, Oral; Animal Feed; Animals; Dose-Response Relationship, | 2008 |
Follicular carcinoma arising from the pyramidal lobe of the thyroid.
Topics: Adenocarcinoma, Follicular; Biopsy, Needle; Chemotherapy, Adjuvant; Female; Humans; Thyroid Neoplasm | 2009 |
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography; | 2010 |
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Child; | 2010 |
Differentiated thyroid carcinoma associated with histological features of Hashimoto's thyroiditis.
Topics: Adenocarcinoma, Follicular; Adolescent; Female; Hashimoto Disease; Humans; Iodide Peroxidase; Thyroi | 2009 |
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Animals; Blotting, Western; Cell Proliferation; Disease Models, Animal; | 2010 |
Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Topics: Adenocarcinoma, Follicular; Analysis of Variance; Animals; Cell Line, Tumor; Cell Proliferation; Cel | 2010 |
A patient with Graves' disease and three types of thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Fatal Outcome; Female; Graves Disease; Humans; Neoplasm | 2010 |
[Outcomes of long-term combined treatment in follicular thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iod | 2010 |
[Follow-up of papillary and follicular thyroid cancer--when and where?].
Topics: Ablation Techniques; Adenocarcinoma, Follicular; Carcinoma, Papillary; Combined Modality Therapy; Di | 2010 |
Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Female; Hashimoto Disease; Humans; | 2011 |
Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; False Negative Reactions; Female; Head and Neck Ne | 2002 |
Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Humans; Iodide Peroxidase; Iodothyronine Deiodinase Type II | 2003 |
Synergistic interaction between excess caffeine and deficient iodine on the promotion of thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.
Topics: Adenocarcinoma, Follicular; Adenoma; Animals; Anti-Infective Agents, Local; Caffeine; Carcinogens; C | 2003 |
Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Enzyme | 2003 |
Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Case-Control Studies; Chemistry, Clin | 2003 |
Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Cohort Studies; Drug Administra | 2003 |
Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal.
Topics: Adenocarcinoma, Follicular; Adolescent; Child; Humans; Iodine Radioisotopes; Retrospective Studies; | 2005 |
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod | 2006 |
Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia.
Topics: Adenocarcinoma, Follicular; Administration, Oral; Animals; Aryl Hydrocarbon Hydroxylases; Carcinogen | 2005 |
Thyroid follicular carcinoma metastasized to the lung, skull, and brain 12 years after initial treatment for thyroid gland--case report.
Topics: Adenocarcinoma, Follicular; Aged; Brain Neoplasms; Cerebral Hemorrhage; Combined Modality Therapy; E | 2006 |
Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mid | 2006 |
[Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy].
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Catheter Ablation; Continuity of Patient Care; Fem | 2006 |
3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod | 2008 |
Management of the hot thyroid nodule.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D | 1995 |
Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Papillary; En | 1994 |
[Hormonal therapy in differentiated carcinoma of the thyroid gland].
Topics: Adenocarcinoma, Follicular; Adenylyl Cyclases; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; H | 1994 |
Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Femal | 1994 |
Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
Topics: Adenocarcinoma, Follicular; Affinity Labels; Butyrates; Butyric Acid; Cycloheximide; Dactinomycin; H | 1994 |
Thyroid hormones in differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Bone Neoplasms; Humans; Iodine Radioisotopes; Thyroglobulin; Thyroid Neo | 1994 |
Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
Topics: Absorptiometry, Photon; Adenocarcinoma, Follicular; Adult; Age Factors; Aged; Bone Density; Carcinom | 1993 |
[Follicular carcinoma of the ectopic lingual thyroid].
Topics: Adenocarcinoma, Follicular; Adult; Combined Modality Therapy; Female; Humans; Radiotherapy; Thyroid | 1993 |
Cutaneous metastasis from follicular carcinoma of the thyroid gland.
Topics: Adenocarcinoma, Follicular; Aged; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Melanoma; R | 1993 |
[T3 hyperthyroidism with metastatic follicular thyroid carcinoma in substitution therapy].
Topics: Adenocarcinoma, Follicular; Adult; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Lymphatic | 1996 |
Thyroid carcinoma in children and adolescents.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adolescent; Carcinoma, Medullary; Child; Comb | 1997 |
[Development of a thyroid carcinoma after irradiation of the head/neck region].
Topics: Adenocarcinoma, Follicular; Aged; Biopsy, Needle; Female; Goiter, Nodular; Humans; Neoplasms, Radiat | 1997 |
Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biological Availability; Carcinoma, Papillary; Chemistry, P | 1997 |
Thyroid storm due to functioning metastatic thyroid carcinoma in a burn patient.
Topics: Adenocarcinoma, Follicular; Burns; Humans; Male; Middle Aged; Thyroid Crisis; Thyroid Neoplasms; Thy | 1997 |
[Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; | 1997 |
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Case-Control Studies; Combined Modality Therapy; F | 1998 |
Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lymph Node E | 1998 |
Radioiodine treatment and oxidative stress in thyroidectomised patients for differentiated thyroid cancers.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers; Carcinoma, Papillary; Erythrocyte Count; Erythrocytes | 1998 |
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Prospect | 1998 |
Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Case-Control Studies; Female; Humans; Iodin | 1998 |
Metastatic follicular thyroid carcinoma to the kidney: a case report.
Topics: Adenocarcinoma, Follicular; Aged; Female; Humans; Iodine Radioisotopes; Kidney Neoplasms; Lymph Node | 1999 |
Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Female; Humans; Immunoassay; Iodin | 1999 |
A clear cell variant of follicular carcinoma presenting as an autonomously functioning thyroid nodule.
Topics: Adenocarcinoma, Follicular; Adult; Biopsy, Needle; Diagnosis, Differential; Female; Humans; Iodine R | 2000 |
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Algorithms; Antineoplastic Agents, Hormonal; Bi | 2000 |
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Follo | 2000 |
Incidentally detected liver metastasis of well-differentiated follicular carcinoma of the thyroid, mimicking ectopic thyroid.
Topics: Adenocarcinoma, Follicular; Cell Differentiation; Choristoma; Diagnosis, Differential; Female; Human | 2000 |
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucos | 2000 |
Serum thyroglobulin as a risk factor for thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Humans; Iceland; Logistic Mod | 2000 |
Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; | 2001 |
Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adrenal Gland Neoplasms; Diagnosis, Differential; Goiter, Nodular; Human | 2001 |
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary | 2002 |
Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Carcinoma, Papillary; Female; Gamma Cameras; H | 2002 |
Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; False | 2002 |
Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Carcinoma, Papillary; Child; Comb | 2002 |
A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Antithyroid Agents; Autoantibodies; Bone Neoplasms; Female; Humans | 2002 |